Abstract
Preliminary data regarding the experience of countries of the Northern Hemisphere with pandemic 2009 A(H1N1) influenza have already appeared in the literature. We aimed to evaluate the available published literature describing the epidemiological features of pandemic influenza. We searched PubMed; 35 studies (14 referred to European countries, eight to the USA, five to Mexico, four to Canada, two to Japan, one to Colombia, and one reviewed relevant data reported worldwide) were included. Considerably high hospitalization, intensive care unit (ICU) admission, and fatality rates (up to 93.8, 36.4, and 38.5%, respectively) among the evaluated cases were reported across studies with available relevant data. Young and middle-aged adults constituted the majority of the evaluated pandemic cases, with different disease severity (as indicated by the level of care and outcome). Yet, substantial percentages of elderly individuals were reported among more severely afflicted cases. Otherwise healthy patients constituted substantial percentages among evaluated cases with different disease severity. Pregnant women, obese, and morbidly obese patients also constituted substantial percentages of the cases involved in the included studies. The evaluation of the currently available published evidence contributes to the clarification of the epidemiological features of pandemic 2009 A(H1N1) influenza, which is useful in terms of the individual and public health perspectives.
Similar content being viewed by others
Introduction
Influenza is an important clinical entity. The burden of this infection is considerable, as it is associated with considerably high hospitalization and mortality rates, as well as with increased direct and indirect costs [1]. The burden of influenza infection became even more pronounced with the emergence of the recent influenza pandemic. Specifically, the effective management of this global threat necessitated the awareness of the respective epidemiological aspects.
Evidence deriving from studies presenting the experience of countries of the Southern Hemisphere with pandemic influenza, as well as preliminary data from the USA, suggests that 2009 pandemic influenza affects mostly populations of younger age [2–5], a fact that is contradictory to the knowledge regarding seasonal influenza, in which severe disease as well as mortality is observed more frequently in elderly populations [6]. Additionally, patients with comorbidity and, specifically, sub-populations such as pregnant women and obese individuals also appear to suffer more severely from pandemic influenza [4, 5].
The aim of this review was to collect and evaluate the available evidence regarding various epidemiological aspects of 2009 H1N1 influenza that was derived from studies, published up to this writing, referring to the experience of countries from the Northern Hemisphere with pandemic influenza.
Data sources
The articles to be included in our review were retrieved from searches performed in the PubMed database. The PubMed database was assessed to the end of November 2009. We used the following search term: “[(swine OR H1N1) AND (flu OR influenza OR virus OR outbreak OR pandemic) AND "last 6 months"]”, which was provided by the PubMed database to its users, in order to enable quick and easy access to the latest H1N1 citations. We also hand-searched the bibliographies of relevant articles.
Study selection criteria
A study was considered as eligible for inclusion in our review if it reported original data regarding epidemiological features of patients of any age with 2009 influenza A (H1N1) infection (either confirmed or probable) and also originated from countries of the Northern Hemisphere. Abstracts presented in scientific conferences were not regarded as eligible for inclusion in our review. Only articles published in the English language were regarded as eligible for inclusion in our review.
Data extraction
Two reviewers (N.V.C and E.K.V.) performed the literature search, assessed the eligibility of relevant studies, and extracted the data, independently. Data obtained from the included articles referred to study characteristics (country, study period, study population), demographic characteristics of the patients (age, sex), any kind of potential risk factors for influenza, comorbidity (such as obesity, pregnancy, respiratory diseases, cardiovascular disease, diabetes mellitus, chronic neurological disease), as well as history of seasonal influenza 2008–2009 vaccination). The above-mentioned data were extracted for the whole patient populations involved in each of the included studies, as well as for the sub-populations of patients with pandemic influenza of different severity, as this was indicated by the level of health-care they received (hospitalized patients, patients admitted in the intensive care unit [ICU]), and the outcome of the influenza infection (fatal cases).
Study characteristics
A total of 35 studies were regarded as eligible for inclusion in our review [2, 4, 7–39]. Specifically, 14 of the 35 included studies referred to European countries [7–20], eight to the USA [2, 4, 21–26], five to Mexico [31–35], four to Canada [27–30], two to Japan [37, 38], one to Colombia [36], whereas the remaining study referred to a specific number of fatal cases associated with pandemic influenza that were reported worldwide up to a specific time point [39]. The data retrieved and evaluated from this specific study referred only to continents or countries of the Northern Hemisphere. The data retrieved from studies originating from European countries, USA and Canada, and from the rest of the world are presented in tabulated form in Table 1, Table 2, and Table 3, respectively.
Four of the 35 included studies referring to Mexico covered a time period starting in March and ending in April [32, 34], May [35], and June [31], respectively. Eleven of the 35 included studies referred to a time period starting from April and ending in May [8, 9, 12, 21–24, 26, 28, 33, 37], four to a period starting from April and ending in June [2, 10, 14, 30], two to a period from April until July [16, 39], four from April until August [4, 7, 13, 27], and one to an extended time period from April to October [15]. Four other studies covered a time period from May until June [11, 19, 20, 38], whereas two studies covered a time period from May until July [29, 36]. Two other studies covered a time period from June to July [18, 25], whereas the remaining study covered a time period from June to September [17]. Additionally, the evaluated population constituted solely of hospitalized cases with 2009 H1N1 influenza in 8 of the 35 included studies, [2, 4, 15, 17, 25, 29, 32, 37] of patients admitted into the ICU in three studies [7, 18, 27], and from fatal cases associated with 2009 H1N1 influenza in one study [39]. Of note, 2 of the 35 included studies involved only pregnant cases [22, 25].
Hospitalization, ICU admission, and fatality rate
The rate of hospitalization among the evaluated pandemic influenza cases ranged between 0 and 93.8% in 13 studies that provided relevant data [8, 10, 11, 13, 14, 19–22, 24, 26, 28, 36]. The rate of admission into the ICU among the evaluated pandemic influenza cases ranged between 0 and 36.4% in four studies [14, 21, 22, 28]. The rate of admission into the ICU among hospitalized cases ranged between 9 and 66.7% in six studies [2, 4, 15, 17, 29, 32]. Specific data are presented in Table 1. The fatality rate among the evaluated pandemic influenza cases was 0% in 13 of the included studies [8–10, 12–14, 16, 19, 20, 24, 26, 28, 37]. However, the respective rates reported from five other studies ranged between 2 and 38.5% [18, 21, 22, 33, 36]. The fatality rate among hospitalized cases ranged between 0 and 38.9% in six of the included studies [2, 4, 15, 17, 29, 32], whereas the fatality rate among cases admitted into the ICU ranged between 25 and 41.4% in three studies [7, 27, 31].
Epidemiological characteristics of cases
In Table 4, we present the percentage of specific epidemiological groups (defined with regard to age, sex, or the presence of risk factors or comorbid conditions) among the patients involved in the respective included studies (stratified with regard to the type of diagnosis, level of health-care they received, and outcome).
Age and sex
Among the evaluated cases of 2009 H1N1 influenza, young and middle-aged adults constituted the majority of the reported cases; the percentages ranged between 13.2 and 83.7% among studies with available relevant data. Older children and adolescents followed, with percentages ranging between 6.3 and 79.5%, and young children with percentages ranging from 2.3 to 62.9%. This observation was consistent regarding the evaluated hospitalized cases. Specific data are presented in Table 4. In two studies with available relevant data, the highest rate of admission into the ICU was observed for young and middle-aged adults (50% [7] and 58.8% [27], respectively), whereas the lowest rate was observed for senior patients (3.1% [7] and 8.3% [27], respectively). Among fatal cases, young and middle-aged adults constituted the majority, with percentages ranging from 65.5 to 91.7%, according to the data provided from six of the included studies [27, 31, 33–35, 39]. Yet, substantial percentages ranging from 4.2 to 20.7% were observed for seniors [27, 31, 33–35, 39].
Considerable differences were not observed between the male and female sex among the evaluated, hospitalized, ICU, and fatal cases. Specific data are presented in Table 4. Yet, men constituted the majority in three studies reporting data for 97 laboratory-confirmed cases [26], 58 hospitalized cases [29], and 32 ICU cases [7]. The respective percentages were 75.3% [26], 60.3% [29], and 73.3% [7].
Seasonal (2008–2009) influenza vaccination
The percentage of patients vaccinated for seasonal (2008–2009) influenza ranged between 3.4 and 66.3% among the evaluated cases in eight studies that provided relevant data [9, 12, 14, 22, 24, 26, 28, 31]. The respective percentage of hospitalized cases ranged between 15.8 and 51.2% in three studies providing relevant data [21, 32, 37], whereas a single study reported a rather low percentage of 6% among ICU cases [27]. No relevant data were available regarding fatal cases.
Comorbidity
Cases without any comorbidity constituted the majority of the evaluated cases in 2 of the 3 studies that provided relevant data [8, 13]. The respective percentages were 96.7% [13] and 75% [31], respectively. Previously healthy cases were also represented by considerably high percentages ranging from 12.1 to 81.6% in nine studies that reported relevant data for hospitalized cases [2, 4, 15, 17, 21, 24, 29, 32, 37]. Previously healthy cases were represented by percentages of up to 46.8% among ICU cases [7, 27, 29] and up to 42.1% among fatal cases [2, 4, 15, 31, 32]. Common types of comorbidity, such as respiratory diseases, including asthma and chronic obstructive pulmonary disease, cardiovascular disease, chronic neurological disease, and diabetes mellitus, were reported among the cases involved in the included studies. Specific data are presented in Table 4.
Pregnancy
Two of the studies included in our review involved exclusively pregnant cases with H1N1 infection [22, 25]. Specifically, 34 pregnant women (31 with laboratory-confirmed infection and three with probable infection) were included in the one study [22]. Fourteen (41.2%) of these 34 pregnant cases were hospitalized, 3 (8.8%) were included in the ICU, and 1 (2.9%) died [22]. The other study recorded seven hospitalized pregnant cases [25]. Regarding the remaining studies, pregnant women constituted 0.2 to 16.7% among the evaluated cases in three studies [11, 13, 26]. Pregnant women constituted 4.5 to 17.4% among the hospitalized cases in five studies that provided relevant data [2, 4, 15, 17, 21]. Among ICU cases, pregnant women were represented by percentages of 11.5% [27] and 18.2% [7] in two other studies that provided relevant data. Among fatal cases, pregnant women were represented by percentages ranging from 2.2 to 15.8% in three studies [33].
Obesity
Obesity was recorded in 0.2 to 36.2% among the evaluated cases in two of the included studies that provided relevant data [13, 31] and 5.7 to 47.6% among hospitalized cases in three studies [2, 4, 29]. Obese patients also constituted 18.8% [7] and 33.3% [27] of the evaluated ICU cases reported in the respective two studies [7, 27]. Among fatal cases, obese patients constituted 39% in a large study involving a total of 1,088 patients and recorded a total of 118 deaths.
Morbidly obese patients (BMI>40) in particular, constituted 13.8% of the evaluated cases in a single study [31], whereas their percentages ranged between 2.2 and 26.0% in three studies that provided relevant data for hospitalized cases [2, 4, 15]. In addition, morbidly obese patients constituted 12.5% of the fatal cases recorded in a large study involving a total of 32 ICU patients [7].
Comparisons between pandemic and seasonal influenza
Three of the 35 included studies provided comparative data regarding a specific period of pandemic influenza and previous seasonal influenza periods [18, 29, 34]. Two of these three studies referred to pediatric populations with 2009 H1N1 infection [18, 29]. Specifically, one of these two studies provided comparative data regarding 13 critically ill pediatric cases of pandemic influenza versus 58 critically ill pediatric cases with seasonal influenza (reported during seasons 2004–2007) [18]. No substantial differences were observed regarding sex between the compared children. The median age of children with pandemic influenza was 9 years compared to 2.7 years of children with seasonal influenza [18]. Regarding the other pediatric study that compared 58 hospitalized children with pandemic influenza with 200 hospitalized children with seasonal influenza (seasons 2004–2005 and 2008–2009), the median age of children with pandemic influenza was 6.4 years compared to 3.3 years of children with seasonal influenza [29].
According to another study that also provided comparative data regarding the age distribution of fatal cases of pandemic influenza versus fatal cases of seasonal influenza (seasons 2006–2008), the percentages of fatal pandemic cases were lower from those of the respective fatal seasonal cases in the age groups 0–4 years and >60 years [34]. Additionally, another study that compared a total of 1,829 confirmed pandemic cases with cases that were found to be negative for H1N1v reported that patients <53 years of age had an increased risk of infection from pandemic influenza in comparison to those that were found to be positive for seasonal H1N1 and H3N2 influenza strains [30].
Discussion
The evaluation of contemporary published evidence regarding the experience of countries of the Northern Hemisphere with 2009 pandemic (H1N1) influenza suggests that pandemic influenza is an infection with a considerable hospitalization, ICU admission, and mortality rate. Specifically, a considerably higher fatality rate was observed in more severely afflicted cases. Young and middle-aged adults constituted the majority of the evaluated cases, followed by older children and adolescents. Yet, considerable percentages of elderly patients were reported among more severely afflicted cases. Men constituted the majority in only three of the evaluated studies involving cases with different disease severity. Despite the fact that considerable percentages of patients without any underlying conditions were observed among the total of the cases involved in the herein reviewed studies, as well as among hospitalized, critically ill, and fatal cases, pregnancy and obesity appear to represent particular risk factors for pandemic (H1N1) 2009 influenza infection, as well as for severe pandemic influenza infection.
Our findings are in accordance with evidence derived from studies focused on the experience gained during the 2009 winter season from countries of the Southern Hemisphere. Specifically, these studies suggest that 2009 pandemic influenza occurs more frequently in younger populations [3–5], whereas fatal outcome can occur at any age [4]. The observed “epidemiological shift” to younger ages appears to be contradictory to the current knowledge regarding seasonal influenza that mostly affects younger children and elderly frail individuals [40]. Of note, a similar “epidemiological shift” to younger ages was observed during previous influenza pandemics [41]. A possible explanation may be the fact that elderly individuals that were infected with previous influenza strains that have antigenic similarities with 2009 H1N1v may have already developed a substantial antibody response to this new pandemic influenza virus. However, the considerable percentages of elderly individuals among critically ill and fatal cases observed in the herein reviewed studies imply that elderly individuals do suffer severely from pandemic influenza. This might be due to the presence of serious comorbidity and inadequate immune response mechanisms in elderly individuals.
Pregnant women constituted a considerable percentage among the total of the evaluated pandemic cases reported in the included studies, as well as among the evaluated hospitalized, critically ill, and fatal cases. This finding is in accordance with the findings of relevant studies from the Southern Hemisphere. However, pregnancy has already been regarded as a risk factor for severe influenza infection, as well as for an adverse outcome of influenza infection, based on the experience from seasonal influenza [42, 43]. A possible explanation for this may be the alterations to the immune response system, as well as psychological alterations that may occur during pregnancy. Notably, a recent review suggests there is a significant relationship between psychosocial factors and the onset or the progression of acute respiratory tract illness [44].
Obese and morbidly obese patients also constituted a considerable proportion of the evaluated cases with pandemic influenza infection of different severity. Specifically, obese and morbidly obese patients represented considerably high percentages among hospitalized, critically ill, and fatal cases. This finding, along with the evidence provided from studies from the Southern Hemisphere [5], imply that obesity and morbid obesity may be regarded as risk factors of severe pandemic influenza infection. Many factors may account for this finding. These may include the inadequate immune response mechanisms in obese patients and the common presence of serious comorbidity. The role of psychological factors should not be underestimated in this specific sub-population either. Recent reviews have also suggested that obese and morbid obese individuals are more likely than people with normal body weight to develop infections of various types of infections, as well to develop serious complications of common infections, such as respiratory infections [45, 46]. The fact that obese patients may suffer more severely from pandemic influenza has considerable implications with regard to the treatment of these patients. Specifically, the adjustment of dosing of anti-influenza agents, in particular, for body weight, may prove to be a necessity, as was suggested for the treatment with antimicrobial agents from a recent review [47].
Our study has limitations that should be taken into consideration before extrapolation of the findings. Firstly, considerable heterogeneity was observed among the included studies regarding the methodology used to identify and present the pandemic cases, the clinical settings, the period to which the study referred, as well as the evaluated populations. This hampered our attempts to perform any statistical analysis and, consequently, the establishment of firm conclusions based on a pooled evaluation of the extracted data. Moreover, the retrospective nature of the collection and presentation of the data regarding the pandemic cases that was used in the majority of the included studies may also induce a bias. However, the herein reviewed data, along with the experience gained from countries of the Southern Hemisphere, may aid considerably in the clarification, at least to some extent, of some of the epidemiological features of pandemic influenza.
In conclusion, the evaluation of the currently available published literature regarding the experience from the Northern Hemisphere with the pandemic 2009 A(H1N1) influenza suggests that pandemic influenza affects younger patients compared to seasonal influenza. Pandemic influenza also seems to be associated with considerable morbidity in the patients that present with serious illness, as well as in otherwise healthy individuals. Pregnancy and obesity may also be regarded as risk factors for both infection as well as severe pandemic influenza infection.
References
Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E et al (2007) The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25(27):5086–5096
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. N Engl J Med 361(20):1935–1944
Kelly H, Grant K (2009) Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 14(31).
Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R et al (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302(17):1896–1902
Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ et al (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361(20):1925–1934
Thompson WW, Comanor L, Shay DK (2006) Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 194(Suppl 2):S82–S91
Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A (2009) Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 13(5):R148
New influenza A(H1N1) investigation teams (2009) New influenza A(H1N1) virus infections in France, April–May 2009. Euro Surveill 14(21).
Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain (2009) New influenza A(H1N1) virus infections in Spain, April–May 2009. Euro Surveill 14(19).
Health Protection Agency; Health Protection Scotland; National Public Health Service for Wales; HPA Northern Ireland Swine influenza investigation teams (2009) Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April–June 2009. Euro Surveill 14(22).
Belgian working group on influenza A(H1N1)v (2009) Influenza A(H1N1)v virus infections in Belgium, May–June 2009. Euro Surveill 14(28).
Ciblak MA, Albayrak N, Odabas Y, Basak Altas A, Kanturvardar M, Hasoksuz M et al (2009) Cases of influenza A(H1N1)v reported in Turkey, May–July 2009. Euro Surveill 14(32).
Gilsdorf A, Poggensee G; Working Group Pandemic Influenza A(H1N1)v (2009) Influenza A(H1N1)v in Germany: the first 10,000 cases. Euro Surveill 14(34).
Hahné S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A et al (2009) Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 14(27).
Cullen G, Martin J, O’Donnell J, Boland M, Canny M, Keane E et al (2009) Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April–3 October 2009. Euro Surveill 14(44).
Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, Bonovas S (2009) Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill 14(29).
Yeung JH, Bailey M, Perkins GD, Smith FG (2009) Presentation and management of critically ill patients with influenza A (H1N1): a UK perspective. Crit Care 13(6):426
Lister P, Reynolds F, Parslow R, Chan A, Cooper M, Plunkett A et al (2009) Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 374(9690):605–607
Smith A, Coles S, Johnson S, Saldana L, Ihekweazu C, O’Moore E (2009) An outbreak of influenza A(H1N1)v in a boarding school in South East England, May–June 2009. Euro Surveill 14(27).
Health Protection Agency West Midlands H1N1v Investigation Team (2009) Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009. Euro Surveill 14(27).
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ et al (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360(25):2605–2615
Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374(9688):451–458
Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA et al (2009) Introduction of a novel swine-origin influenza A (H1N1) virus into Milwaukee, Wisconsin in 2009. Viruses 1(1):72–83
Centers for Disease Control and Prevention (CDC) (2009) Novel influenza A (H1N1) virus infections among health-care personnel—United States, April–May 2009. MMWR Morb Mortal Wkly Rep 58(23):641–645
Saleeby E, Chapman J, Morse J, Bryant A (2009) H1N1 influenza in pregnancy: cause for concern. Obstet Gynecol 114(4):885–891
Crum-Cianflone NF, Blair PJ, Faix D, Arnold J, Echols S, Sherman SS et al (2009) Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis 49(12):1801–1810
Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J et al (2009) Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302(17):1872–1879
Cutler J, Schleihauf E, Hatchette TF, Billard B, Watson-Creed G, Davidson R et al (2009) Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181(3–4):159–163
O’Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D (2010) Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 182(1):39–44
Fisman DN, Savage R, Gubbay J, Achonu C, Akwar H, Farrell DJ (2009) Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 361(20):2000–2001
Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A et al (2009) Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302(17):1880–1887
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E et al (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361(7):680–689
[No authors listed] (2009) Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 84(21):185–189
Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M et al (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361(7):674–679
Fajardo-Dolci GE, Hernández-Torres F, Santacruz-Varela J, Rodríguez-Suárez J, Lamy P, Arboleya-Casanova H et al (2009) Epidemiological profile of mortality due to human influenza A (H1N1) in Mexico. Salud Pública Méx 51(5):361–371
Castro-Jiménez MA, Castillo-Pabón JO, Rey-Benito GJ, Pulido-Domínguez PA, Barbosa-Ramírez J, Velandia-Rodriguez DA et al (2009) Epidemiologic analysis of the laboratory-confirmed cases of influenza A(H1N1)v in Colombia. Euro Surveill 14(30):19284
[No authors listed] (2009) Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 84(24):237–244
Nishiura H, Castillo-Chavez C, Safan M, Chowell G (2009) Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill 14(22).
Vaillant L, La Ruche G, Tarantola A, Barboza P (2009) Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14(33).
Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ et al (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289(2):179–186
Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K (1998) Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178(1):53–60
Dodds L, McNeil SA, Fell DB, Allen VM, Coombs A, Scott J et al (2007) Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 176(4):463–468
Schanzer DL, Langley JM, Tam TW (2007) Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can 29(8):622–629
Falagas M, Karamanidou C, Kastoris AC, Karlis G, Rafailidis PI (2009) Psychosocial factors and susceptibility to or outcome of acute respiratory tract infections. Int J Tuberc Lung Dis 14(2):141–148
Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE (2009) Effect of body mass index on the outcome of infections: a systematic review. Obes Rev 10(3):280–289
Falagas ME, Kompoti M (2006) Obesity and infection. Lancet Infect Dis 6(7):438–446
Falagas ME, Karageorgopoulos DE (2010) Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet 375(9710):248–251
Funding
None.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Falagas, M.E., Cholevas, N.V., Kapaskelis, A.M. et al. Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere. Eur J Clin Microbiol Infect Dis 29, 1327–1347 (2010). https://doi.org/10.1007/s10096-010-1002-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-010-1002-3